{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:23:41Z","timestamp":1777508621817,"version":"3.51.4"},"reference-count":41,"publisher":"The Endocrine Society","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST 104-2321-B-039-007-MY3"],"award-info":[{"award-number":["MOST 104-2321-B-039-007-MY3"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU108-MF-57"],"award-info":[{"award-number":["CMU108-MF-57"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health and Welfare of Taiwan","award":["MOHW109-MHAOH-M-113-112002l"],"award-info":[{"award-number":["MOHW109-MHAOH-M-113-112002l"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Comorbid depression in patients with diabetes deteriorates the prognosis. Antidepressants might attenuate the adverse effects of depression; however, they are associated with cardiometabolic adverse effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to explore the association between antidepressant treatment and advanced diabetic complications and mortality among patients with depression and diabetes mellitus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a nationwide retrospective cohort study of 36 276 patients with depression and newly treated diabetes mellitus using Taiwan\u2019s universal health insurance database. Antidepressant treatment patterns within a 6-month window were classified into none, poor, partial, and regular use, and we accounted for time-dependent variables in the Cox proportional hazards regression analysis with adjustment for time-dependent comorbidity and concomitant use of medications. Different classes of antidepressants were compared. Macro- and microvascular complications, as well as all-cause mortality, were the main outcomes. Benzodiazepines were chosen as negative control exposure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with poor use of antidepressants, regular use was associated with a 0.92-fold decreased risk of macrovascular complications and a 0.86-fold decreased risk of all-cause mortality but not associated with microvascular complications. Regular use of selective serotonin reuptake inhibitors was associated with a 0.83- and 0.75-fold decreased risk of macrovascular complications and all-cause mortality, respectively. Regular use of tricyclic or tetracyclic antidepressants was associated with a 0.78-fold decreased risk of all-cause mortality. Regular use of benzodiazepine showed no association with diabetic outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Regular antidepressant use was associated with lower risk of advanced diabetic complications compared with poor adherence. Clinicians should emphasize antidepressant treatment adherence among patients with depression and diabetes mellitus.<\/jats:p><\/jats:sec>","DOI":"10.1210\/clinem\/dgab443","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T13:01:12Z","timestamp":1626267672000},"source":"Crossref","is-referenced-by-count":10,"title":["Associations Between Antidepressant Use and Advanced Diabetes Outcomes in Patients with Depression and Diabetes Mellitus"],"prefix":"10.1210","author":[{"given":"Chi-Shin","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Psychiatry, National Taiwan University Hospital, Taipei, 100, Taiwan"},{"name":"National Center for Geriatrics and Welfare Research, National Health Research Institutes, Zhunan, 350, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le-Yin","family":"Hsu","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, 100, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2522-7805","authenticated-orcid":false,"given":"Yi-Jiun","family":"Pan","sequence":"additional","affiliation":[{"name":"School of Medicine, China Medical University, Taichung, 404, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8466-2698","authenticated-orcid":false,"given":"Shi-Heng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Occupational Safety and Health, China Medical University, Taichung, 406, Taiwan"},{"name":"Department of Public Health, China Medical University, Taichung, 406, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"issue":"5","key":"2021071413010539600_CIT0001","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2337\/dc11-2055","article-title":"Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies","volume":"35","author":"Pan","year":"2012","journal-title":"Diabetes Care."},{"issue":"2","key":"2021071413010539600_CIT0002","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol."},{"issue":"3","key":"2021071413010539600_CIT0003","doi-asserted-by":"crossref","first-page":"e57058","DOI":"10.1371\/journal.pone.0057058","article-title":"Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis","volume":"8","author":"van Dooren","year":"2013","journal-title":"Plos One."},{"issue":"e96","key":"2021071413010539600_CIT0004","first-page":"1","article-title":"Association of depression and diabetes complications and mortality: a population-based cohort study","volume":"29","author":"Wu","year":"2020","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"4","key":"2021071413010539600_CIT0005","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1176\/appi.focus.9.4.500","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression","volume":"9","author":"Grunze","year":"2011","journal-title":"Focus"},{"issue":"7","key":"2021071413010539600_CIT0006","doi-asserted-by":"crossref","first-page":"e0182088","DOI":"10.1371\/journal.pone.0182088","article-title":"The risk of new-onset diabetes in antidepressant users - a systematic review and meta-analysis","volume":"12","author":"Salvi","year":"2017","journal-title":"Plos One."},{"issue":"10","key":"2021071413010539600_CIT0007","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.2337\/dc13-0560","article-title":"Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review","volume":"36","author":"Barnard","year":"2013","journal-title":"Diabetes Care."},{"issue":"1","key":"2021071413010539600_CIT0008","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4088\/JCP.13m08421","article-title":"Long-term antidepressant use and the risk of type 2 diabetes mellitus: a population-based, nested case-control study in Taiwan","volume":"75","author":"Wu","year":"2014","journal-title":"J Clin Psychiatry."},{"issue":"5","key":"2021071413010539600_CIT0009","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00228-007-0441-y","article-title":"The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports","volume":"64","author":"Derijks","year":"2008","journal-title":"Eur J Clin Pharmacol."},{"issue":"10","key":"2021071413010539600_CIT0010","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4088\/JCP.09r05346blu","article-title":"Antidepressants and body weight: a comprehensive review and meta-analysis","volume":"71","author":"Serretti","year":"2010","journal-title":"J Clin Psychiatry."},{"issue":"1","key":"2021071413010539600_CIT0011","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/YCO.0b013e32835a4206","article-title":"Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults","volume":"26","author":"Deuschle","year":"2013","journal-title":"Curr Opin Psychiatry."},{"issue":"8","key":"2021071413010539600_CIT0012","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jdiacomp.2015.06.009","article-title":"The association of antidepressant medications and diabetic retinopathy among people with diabetes","volume":"29","author":"Yekta","year":"2015","journal-title":"J Diabetes Complications."},{"issue":"10","key":"2021071413010539600_CIT0013","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1210\/jc.2018-02362","article-title":"Antidepressants reduced risk of mortality in patients with diabetes mellitus: a population-based cohort study in Taiwan","volume":"104","author":"Chen","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021071413010539600_CIT0014","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00228-016-2187-x","article-title":"Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies","volume":"73","author":"Biffi","year":"2017","journal-title":"Eur J Clin Pharmacol."},{"issue":"3","key":"2021071413010539600_CIT0015","first-page":"157","article-title":"Accuracy of diabetes diagnosis in health insurance claims data in Taiwan","volume":"104","author":"Lin","year":"2005","journal-title":"J Formos Med Assoc."},{"key":"2021071413010539600_CIT0016","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jad.2019.09.044","article-title":"Using text mining to extract depressive symptoms and to validate the diagnosis of major depressive disorder from electronic health records","volume":"260","author":"Wu","year":"2020","journal-title":"J Affect Disord."},{"issue":"3","key":"2021071413010539600_CIT0017","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the National health insurance research database with ischemic stroke cases in Taiwan","volume":"20","author":"Cheng","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"6","key":"2021071413010539600_CIT0018","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2188\/jea.JE20140076","article-title":"Validation of acute myocardial infarction cases in the national health insurance research database in taiwan","volume":"24","author":"Cheng","year":"2014","journal-title":"J Epidemiol."},{"key":"2021071413010539600_CIT0019","volume-title":"Guidelines for ATC Classification and DDD Assignment","author":"WHO Collaborating Centre for Drug Statistic Methodology"},{"key":"2021071413010539600_CIT0020","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2147\/PPA.S136890","article-title":"An upper and lower bound of the Medication Possession Ratio","volume":"11","author":"Sperber","year":"2017","journal-title":"Patient Prefer Adherence."},{"key":"2021071413010539600_CIT0021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1472-6904-4-3","article-title":"Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-blind, placebo-controlled, randomized cross-over trial [ISRCTN08745124]","volume":"4","author":"Chevassus","year":"2004","journal-title":"BMC Clin Pharmacol."},{"issue":"8","key":"2021071413010539600_CIT0022","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2337\/diacare.18.8.1133","article-title":"Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial","volume":"18","author":"Lustman","year":"1995","journal-title":"Diabetes Care."},{"issue":"12","key":"2021071413010539600_CIT0023","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archpsyc.55.12.1128","article-title":"The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression","volume":"55","author":"Melfi","year":"1998","journal-title":"Arch Gen Psychiatry."},{"issue":"9","key":"2021071413010539600_CIT0024","doi-asserted-by":"crossref","first-page":"e886","DOI":"10.1038\/tp.2016.156","article-title":"Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model","volume":"6","author":"Lopez-Vilchez","year":"2016","journal-title":"Transl Psychiatry."},{"issue":"4","key":"2021071413010539600_CIT0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2190\/KKGW-Y42P-BAAB-JDJ0","article-title":"Does antidepressant adherence have an effect on glycemic control among diabetic antidepressant users?","volume":"34","author":"Bambauer","year":"2004","journal-title":"Int J Psychiatry Med."},{"issue":"2","key":"2021071413010539600_CIT0026","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jdiacomp.2015.10.017","article-title":"The association between antidepressant use and glycemic control in the Southern Community Cohort Study (SCCS)","volume":"30","author":"Kammer","year":"2016","journal-title":"J Diabetes Complications."},{"issue":"7258","key":"2021071413010539600_CIT0027","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ."},{"issue":"7557","key":"2021071413010539600_CIT0028","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","article-title":"A meta-analysis of the association between adherence to drug therapy and mortality","volume":"333","author":"Simpson","year":"2006","journal-title":"BMJ."},{"issue":"4","key":"2021071413010539600_CIT0029","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2337\/dc14-2098","article-title":"Determinants of adherence to diabetes medications: findings from a large pharmacy claims database","volume":"38","author":"Kirkman","year":"2015","journal-title":"Diabetes Care."},{"issue":"26","key":"2021071413010539600_CIT0030","doi-asserted-by":"crossref","first-page":"e20800","DOI":"10.1097\/MD.0000000000020800","article-title":"A study on the impact of poor medication adherence on health status and medical expense for diabetes mellitus patients in Taiwan: a longitudinal panel data analysis","volume":"99","author":"Lin","year":"2020","journal-title":"Medicine"},{"issue":"3","key":"2021071413010539600_CIT0031","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.genhosppsych.2012.12.003","article-title":"Persistence of antidepressant treatment for depressive disorder in Taiwan","volume":"35","author":"Wu","year":"2013","journal-title":"Gen Hosp Psychiatry."},{"issue":"1","key":"2021071413010539600_CIT0032","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/YIC.0b013e3282f1c1d8","article-title":"Six-month compliance with antidepressant medication in the treatment of major depressive disorder","volume":"23","author":"Demyttenaere","year":"2008","journal-title":"Int Clin Psychopharmacol."},{"key":"2021071413010539600_CIT0033","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/PPA.S29716","article-title":"Treatment-resistant depression: therapeutic trends, challenges, and future directions","volume":"6","author":"Al-Harbi","year":"2012","journal-title":"Patient Prefer Adherence."},{"key":"2021071413010539600_CIT0034","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12991-019-0248-0","article-title":"All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population","volume":"18","author":"Li","year":"2019","journal-title":"Ann Gen Psychiatry."},{"issue":"4","key":"2021071413010539600_CIT0035","first-page":"98","article-title":"A review on drug-drug and drug-food interactions in patients during the treatment of diabetes mellitus","volume":"4","author":"Sharma","year":"2015","journal-title":"Int J Pharmacol Clin Sci."},{"issue":"10128","key":"2021071413010539600_CIT0036","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet."},{"issue":"5","key":"2021071413010539600_CIT0037","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00023210-200923050-00006","article-title":"Mirtazapine","volume":"23","author":"Croom","year":"2009","journal-title":"CNS Drugs"},{"issue":"10","key":"2021071413010539600_CIT0038","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4088\/JCP.v59n1002","article-title":"Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients","volume":"59","author":"Thase","year":"1998","journal-title":"J Clin Psychiatry."},{"issue":"2","key":"2021071413010539600_CIT0039","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00392-020-01697-8","article-title":"The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis","volume":"110","author":"Fernandes","year":"2021","journal-title":"Clin Res Cardiol."},{"key":"2021071413010539600_CIT0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2288-2-8","article-title":"Do multiple outcome measures require p-value adjustment?","volume":"2","author":"Feise","year":"2002","journal-title":"BMC Med Res Methodol."},{"issue":"1","key":"2021071413010539600_CIT0041","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab443\/38948834\/dgab443.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab443\/38948834\/dgab443.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T04:39:55Z","timestamp":1672807195000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article\/doi\/10.1210\/clinem\/dgab443\/6321009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab443","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]},"article-number":"dgab443"}}